Rocket Pharmaceuticals, Inc. Common Stock (RCKT) is a publicly traded Healthcare sector company. As of August 3, 2026, RCKT trades at $3.16 with a market cap of $339.59M and a P/E ratio of -1.55. RCKT moved +0.00% today. Year to date, RCKT is -9.06%; over the trailing twelve months it is +1.97%. Its 52-week range spans $2.19 to $15.00. Analyst consensus is buy with an average price target of $11.80. Rallies surfaces RCKT's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
RCKT financials on Rallies include revenue, net income, EPS, valuation metrics, market cap, price history, and balance sheet context. RCKT recently traded at $3.16. Market cap is $339.59M. P/E ratio is -1.55. Revenue is $0.
| Metric | Value |
|---|---|
| Price | $3.16 |
| Market Cap | $339.59M |
| P/E Ratio | -1.55 |
| EPS | $-2.01 |
| Dividend Yield | 0.00% |
| 52-Week High | $15.00 |
| 52-Week Low | $2.19 |
| Volume | 494.18K |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $-223.12M |
| Gross Margin | 0.00% |
7 analysts cover RCKT: 0 strong buy, 5 buy, 2 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $11.80.